These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 4537496

  • 21. Molecular genetics of Oguchi disease, fundus albipunctatus, and other forms of stationary night blindness: LVII Edward Jackson Memorial Lecture.
    Dryja TP.
    Am J Ophthalmol; 2000 Nov; 130(5):547-63. PubMed ID: 11078833
    [Abstract] [Full Text] [Related]

  • 22. Retinal toxic effects associated with intravitreal fomivirsen.
    Amin HI, Ai E, McDonald HR, Johnson RN.
    Arch Ophthalmol; 2000 Mar; 118(3):426-7. PubMed ID: 10721973
    [No Abstract] [Full Text] [Related]

  • 23. Deferoxamine-induced electronegative ERG responses.
    Jauregui R, Park KS, Bassuk AG, Mahajan VB, Tsang SH.
    Doc Ophthalmol; 2018 Aug; 137(1):15-23. PubMed ID: 29770904
    [Abstract] [Full Text] [Related]

  • 24. [Fundus flavimaculatus. Clinical, functional and genetic study].
    Babel J.
    Arch Ophtalmol Rev Gen Ophtalmol; 1972 Feb; 32(2):109-21. PubMed ID: 4262401
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Fluorescein angiographic changes in acute toxic retinopathy associated with polypharmacy.
    Shaikh S, Shaikh N, Blumenkranz MS.
    Retina; 2000 Feb; 20(6):685-8. PubMed ID: 11131433
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Central and peripheral vision loss associated with nefazodone usage.
    Luu C, Kiely P, Crewther D, Kowal L, Crewther S.
    Doc Ophthalmol; 2003 May; 106(3):319-25. PubMed ID: 12737510
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Chloroquine-related myasthenic syndrome with severe retinopathy.
    Ritenour RJ, Cruess AF, Mishra AV.
    Can J Ophthalmol; 2008 Apr; 43(2):241-3. PubMed ID: 18347635
    [No Abstract] [Full Text] [Related]

  • 34. Multifocal electroretinographic evaluation of long-term hydroxychloroquine users.
    Maturi RK, Yu M, Weleber RG.
    Arch Ophthalmol; 2004 Jul; 122(7):973-81. PubMed ID: 15249360
    [Abstract] [Full Text] [Related]

  • 35. [Action of synthetic hypophyseal neuropeptides on the work of the human visual analyzer].
    Kolbanov VV, Bakharev VD, Ryzhova LA, Zagradskiĭ PV, Nezavibat'ko VN.
    Fiziol Cheloveka; 1984 Jul; 10(3):358-63. PubMed ID: 6099810
    [No Abstract] [Full Text] [Related]

  • 36. Comparison of screening procedures in hydroxychloroquine toxicity.
    Marmor MF.
    Arch Ophthalmol; 2012 Apr; 130(4):461-9. PubMed ID: 22159170
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Lithium effects on ophthalmological-electrophysiological parameters in young healthy volunteers.
    Ullrich A, Adamczyk J, Zihl J, Emrich HM.
    Acta Psychiatr Scand; 1985 Aug; 72(2):113-9. PubMed ID: 4050503
    [Abstract] [Full Text] [Related]

  • 40. Fluorescein angiography in retinitis pigmentosa.
    Krill AE, Archer D, Newell FW.
    Am J Ophthalmol; 1970 May; 69(5):826-35. PubMed ID: 5441355
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.